Wilson Tremika Le-Shan, Hattangady Namita, Lerario Antonio Marcondes, Williams Carmen, Koeppe Erika, Quinonez Shane, Osborne Jenae, Cha Kelly B, Else Tobias
Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI, 48109, USA.
Division of Cancer Genetics, Northwestern Medicine, Chicago, IL, 60611, USA.
Fam Cancer. 2017 Oct;16(4):561-566. doi: 10.1007/s10689-017-9984-y.
Melanomas are associated with several hereditary conditions. We present a large family with several family members affected with primary melanomas and dysplastic nevi as well as thyroid cancer and other malignant tumors. Clinical work-up did not reveal a mutation in any of the genes usually considered with evaluation for predisposition to melanoma (BRCA1/2, CDKN2A, CDK4, PTEN, TP53). Whole exome sequencing of five affected family members showed a new variant in POT1. POT1 is associated with the telomere shelterin complex that regulates telomere protection and telomerase access. Germline mutations in POT1 were recently shown to be associated with hereditary predisposition to melanoma. Our findings support a role of POT1 germline mutations in cancer predisposition beyond melanoma development, suggesting a broader phenotype of the POT1-associated tumor predisposition syndrome that might also include thyroid cancer as well as possibly other malignant tumors.
黑色素瘤与多种遗传性疾病相关。我们报告了一个大家族,其中有多名家庭成员患有原发性黑色素瘤、发育异常痣,以及甲状腺癌和其他恶性肿瘤。临床检查未发现通常在评估黑色素瘤易感性时所考虑的任何基因(BRCA1/2、CDKN2A、CDK4、PTEN、TP53)发生突变。对五名受影响家庭成员进行的全外显子组测序显示POT1基因有一个新的变异。POT1与端粒保护蛋白复合体相关,该复合体调节端粒保护和端粒酶的作用。最近研究表明,POT1的种系突变与黑色素瘤的遗传性易感性有关。我们的研究结果支持POT1种系突变在黑色素瘤发生以外的癌症易感性中所起的作用,提示POT1相关肿瘤易感性综合征可能具有更广泛的表型,其中可能还包括甲状腺癌以及其他恶性肿瘤。